Pharmaceutical Executive-09-01-2006

Pharmaceutical Executive
Column

September 01, 2006

It's clear CME is becoming an important part of global healthcare, and there's no better time for pharma companies to capitalize on this growing trend. There's enormous opportunity, but it must be tailored to the distinct clinical environment of each country.